MedPath

A Randomized Controlled Trial of Intramuscular Gonadotropin-Releasing Hormone (GnRH)-analogue Stimulation Test Compared to Subcutaneous Injection to Diagnose in Girls with Central Precocious Puberty

Phase 1
Recruiting
Conditions
maximum LH level(tmax) for the diagnosis of CPP girls after GnRH-analogue stimulation test
Central precocious puberty, diagnosis, Intramuscular, GnRH-analogue stimulation test
Registration Number
TCTR20240719003
Lead Sponsor
Research Affair Faculty of Medicine Chulalonkorn
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
52
Inclusion Criteria

Girls who presented with breast developed before 8 years at KCMH between the years 2024 and 2025 will be recruited.

Exclusion Criteria

Exogenous hormonal use, Congenital adrenal hyperplasia, Peripheral precocious puberty (Adrenal tumor, Ovarian tumor, or cyst, etc.)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the time to the maximum LH level (tmax) at maximum LH level Electrochemiluminescence immunoassay (ECLIA)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath